Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 13
Submit an article Journal homepage
123
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia

Junichi Mukaea Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Daichi Sadatob Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;c Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Takashi Toyaa Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7436-972X
ORCID Icon,
Satoru Watanabed Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan
,
Chizuko Hiramab Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;c Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Ryosuke Konumaa Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Hiroaki Shimizua Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Yuho Najimaa Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Takeshi Kobayashia Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Motohiro Katoe Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
,
Kentaro Ohkid Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan
,
Keisuke Obokic Research Center for Genome & Medical Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Hironori Haradaa Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;f School of Life Sciences, Laboratory of Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan
,
Kazuteru Ohashia Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
,
Takao Deguchie Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
,
Yuka Haradab Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
&
Noriko Dokia Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
 show all
Pages 3261-3264 | Received 01 Jul 2022, Accepted 15 Aug 2022, Published online: 14 Sep 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Acknowledgements

The authors thank the patients who participated in the study. The authors also thank Junko Ohta for her technical assistance. The authors thank Editage (www.editage.com) for English language editing.

Author contributions

J.M., D.S., T.T., and Y.H. designed the study. J.M., T.T., R.K., H.S., Y.N., T.K., K. Ohashi, and N.D. provided medical treatment to the patient and collected the clinical data. T.T. collected the clinical samples. S.W., K. Ohki, M.K., and T.D. underwent JAK2 break-apart FISH and FCM-MRD analyses. D.S., C.H., and Y.H. performed sequencing analyses. J.M., D.S., and T.T. wrote the manuscript and created figures. K. Oboki, H. H., K. Ohashi, Y. H., and N. D. supervised the study. All authors have read and approved the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.